Artificial Larynx Implant Feasible After Total Laryngectomy

Share this content:
Artificial Larynx Implant Feasible After Total Laryngectomy
Artificial Larynx Implant Feasible After Total Laryngectomy

THURSDAY, Jan. 5, 2017 (HealthDay News) -- An artificial larynx has provided long-term relief for a throat cancer patient in France who had a total laryngectomy, according to a letter to the editor published in the Jan. 5 issue of the New England Journal of Medicine.

The 56-year-old man can now speak with an intelligible whisper and breathe normally, lead author Nihal Engin Vrana, Ph.D., vice president of Protip Medical, the French company that created the artificial larynx, told HealthDay.

The patient, who lives in Alsace, received the implant in 2015. He has lived well with it for longer than 16 months, according to the authors. The patient also has a fully restored sense of smell, which had been compromised by removal of his larynx.

"The device contains a permanent titanium tracheal prosthesis with a porous distal end to improve soft-tissue integration and a removable titanium open-ventilation cap with a conformation that allows the continuous passage of air while protecting the patient's airway from aspiration," the authors write. "This cap allows the patient to breathe and drink fluids. When the patient coughs, the upper flap can open transiently to allow the expulsion of bronchopulmonary secretions."

Funding for the research was provided in part by Protip Medical.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »